Concepedia
Statistics
Publications
46
Citations
3K
H-Index
27
Active since
1985
Affiliations
Gilead Sciences (United States)(Current)
Medical University of Vienna
Johns Hopkins Medicine
Texas Liver Institute
The University of Texas at San Antonio Health Science Center
Kathryn Kersey is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and viral hepatitis.
Publications per year
1985–2024
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 266 citations
Medicine, Internal Medicine, Pathology +17
The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection
William F. Balistreri, Karen F. Murray, Philip Rosenthal et al. · Hepatology · 2016 · 197 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
Peter Ruane, Dani Ain, Richard Stryker et al. · Journal of Hepatology · 2014 · 165 citations · Full text
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
Jeffrey E. Lancet, Ivana Gojo, Michael Burton et al. · Leukemia · 2010 · 155 citations
Medicine, Pharmacology, Pharmacotherapy +13
1–5 of 46